Edwards Historical Balance Sheet

EW Stock

USD 70.91 0.28 0.39%

Trend analysis of Edwards Lifesciences Corp balance sheet accounts such as Total Current Liabilities of 1.6 B provides information on Edwards Lifesciences' total assets, liabilities, and equity, which is the actual value of Edwards Lifesciences Corp to its prevalent stockholders. By breaking down trends over time using Edwards Lifesciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Edwards Lifesciences Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Edwards Lifesciences Corp is a good buy for the upcoming year.

Edwards Lifesciences Inventory

1.14 Billion

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

About Edwards Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Edwards Lifesciences Corp at a specified time, usually calculated after every quarter, six months, or one year. Edwards Lifesciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Edwards Lifesciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Edwards currently owns. An asset can also be divided into two categories, current and non-current.

Edwards Lifesciences Balance Sheet Chart

At this time, Edwards Lifesciences' Good Will is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 13.7 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 548 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Edwards Lifesciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Edwards Lifesciences Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Edwards Lifesciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Edwards Lifesciences Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Edwards Lifesciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	673.3M	846.8M	1.2B	1.3B
Total Assets	8.3B	9.4B	13.1B	13.7B

Other Current Liab Total Assets

Edwards Lifesciences balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total	Other Liab	Net Debt	Accounts Payable	Cash	Other Assets	Long Term Debt
Total Assets		0.84	0.92	0.99	0.93	0.96	0.98	0.9	0.9	0.69	0.92	-0.94	0.59	0.95	0.98	-0.79	0.89	0.96	0.97	0.38	0.83	-0.85	0.66	0.91	0.81	0.32
Other Current Liab	0.84		0.65	0.86	0.76	0.9	0.8	0.85	0.79	0.49	0.71	-0.78	0.35	0.79	0.87	-0.86	0.62	0.84	0.84	0.07	0.56	-0.8	0.44	0.79	0.7	0.25
Total Current Liabilities	0.92	0.65		0.87	0.83	0.8	0.91	0.77	0.79	0.69	0.9	-0.87	0.62	0.89	0.85	-0.56	0.93	0.84	0.88	0.54	0.87	-0.69	0.61	0.8	0.7	0.24
Total Stockholder Equity	0.99	0.86	0.87		0.91	0.98	0.97	0.93	0.91	0.63	0.91	-0.91	0.48	0.93	0.98	-0.83	0.82	0.96	0.97	0.27	0.76	-0.89	0.65	0.92	0.79	0.25
Property Plant And Equipment Net	0.93	0.76	0.83	0.91		0.87	0.96	0.76	0.7	0.83	0.86	-0.86	0.68	0.97	0.95	-0.71	0.87	0.96	0.85	0.36	0.86	-0.66	0.82	0.72	0.85	0.34
Retained Earnings	0.96	0.9	0.8	0.98	0.87		0.92	0.97	0.92	0.58	0.83	-0.88	0.42	0.9	0.97	-0.92	0.75	0.94	0.96	0.21	0.66	-0.89	0.54	0.91	0.77	0.26
Non Current Assets Total	0.98	0.8	0.91	0.97	0.96	0.92		0.84	0.81	0.74	0.94	-0.92	0.63	0.96	0.96	-0.73	0.9	0.95	0.92	0.41	0.87	-0.76	0.76	0.83	0.81	0.33
Non Currrent Assets Other	0.9	0.85	0.77	0.93	0.76	0.97	0.84		0.91	0.46	0.8	-0.81	0.26	0.84	0.9	-0.9	0.65	0.88	0.93	0.15	0.54	-0.91	0.44	0.92	0.71	0.13
Cash And Short Term Investments	0.9	0.79	0.79	0.91	0.7	0.92	0.81	0.91		0.4	0.78	-0.86	0.38	0.76	0.87	-0.79	0.74	0.79	0.97	0.27	0.63	-0.95	0.33	0.99	0.66	0.26
Net Receivables	0.69	0.49	0.69	0.63	0.83	0.58	0.74	0.46	0.4		0.61	-0.59	0.83	0.81	0.69	-0.48	0.77	0.75	0.58	0.47	0.77	-0.36	0.76	0.41	0.64	0.44
Good Will	0.92	0.71	0.9	0.91	0.86	0.83	0.94	0.8	0.78	0.61		-0.88	0.51	0.89	0.87	-0.56	0.84	0.87	0.86	0.4	0.82	-0.76	0.77	0.83	0.74	0.24
Common Stock Shares Outstanding	-0.94	-0.78	-0.87	-0.91	-0.86	-0.88	-0.92	-0.81	-0.86	-0.59	-0.88		-0.61	-0.89	-0.9	0.71	-0.9	-0.88	-0.92	-0.49	-0.82	0.75	-0.56	-0.86	-0.77	-0.47
Non Current Liabilities Total	0.59	0.35	0.62	0.48	0.68	0.42	0.63	0.26	0.38	0.83	0.51	-0.61		0.63	0.53	-0.3	0.84	0.54	0.5	0.76	0.86	-0.24	0.57	0.38	0.62	0.74
Inventory	0.95	0.79	0.89	0.93	0.97	0.9	0.96	0.84	0.76	0.81	0.89	-0.89	0.63		0.95	-0.75	0.88	0.98	0.9	0.37	0.84	-0.73	0.74	0.79	0.85	0.3
Other Current Assets	0.98	0.87	0.85	0.98	0.95	0.97	0.96	0.9	0.87	0.69	0.87	-0.9	0.53	0.95		-0.84	0.82	0.98	0.95	0.27	0.77	-0.84	0.67	0.87	0.84	0.27
Other Stockholder Equity	-0.79	-0.86	-0.56	-0.83	-0.71	-0.92	-0.73	-0.9	-0.79	-0.48	-0.56	0.71	-0.3	-0.75	-0.84		-0.54	-0.81	-0.82	-0.08	-0.42	0.78	-0.33	-0.77	-0.68	-0.28
Total Liab	0.89	0.62	0.93	0.82	0.87	0.75	0.9	0.65	0.74	0.77	0.84	-0.9	0.84	0.88	0.82	-0.54		0.81	0.84	0.67	0.97	-0.61	0.63	0.74	0.77	0.5
Property Plant And Equipment Gross	0.96	0.84	0.84	0.96	0.96	0.94	0.95	0.88	0.79	0.75	0.87	-0.88	0.54	0.98	0.98	-0.81	0.81		0.91	0.28	0.76	-0.77	0.73	0.81	0.82	0.27
Total Current Assets	0.97	0.84	0.88	0.97	0.85	0.96	0.92	0.93	0.97	0.58	0.86	-0.92	0.5	0.9	0.95	-0.82	0.84	0.91		0.32	0.75	-0.92	0.5	0.97	0.77	0.29
Short Long Term Debt Total	0.38	0.07	0.54	0.27	0.36	0.21	0.41	0.15	0.27	0.47	0.4	-0.49	0.76	0.37	0.27	-0.08	0.67	0.28	0.32		0.62	-0.03	0.33	0.25	0.34	0.74
Other Liab	0.83	0.56	0.87	0.76	0.86	0.66	0.87	0.54	0.63	0.77	0.82	-0.82	0.86	0.84	0.77	-0.42	0.97	0.76	0.75	0.62		-0.53	0.72	0.65	0.8	0.45
Net Debt	-0.85	-0.8	-0.69	-0.89	-0.66	-0.89	-0.76	-0.91	-0.95	-0.36	-0.76	0.75	-0.24	-0.73	-0.84	0.78	-0.61	-0.77	-0.92	-0.03	-0.53		-0.36	-0.97	-0.65	-0.09
Accounts Payable	0.66	0.44	0.61	0.65	0.82	0.54	0.76	0.44	0.33	0.76	0.77	-0.56	0.57	0.74	0.67	-0.33	0.63	0.73	0.5	0.33	0.72	-0.36		0.4	0.65	0.24
Cash	0.91	0.79	0.8	0.92	0.72	0.91	0.83	0.92	0.99	0.41	0.83	-0.86	0.38	0.79	0.87	-0.77	0.74	0.81	0.97	0.25	0.65	-0.97	0.4		0.71	0.24
Other Assets	0.81	0.7	0.7	0.79	0.85	0.77	0.81	0.71	0.66	0.64	0.74	-0.77	0.62	0.85	0.84	-0.68	0.77	0.82	0.77	0.34	0.8	-0.65	0.65	0.71		0.34
Long Term Debt	0.32	0.25	0.24	0.25	0.34	0.26	0.33	0.13	0.26	0.44	0.24	-0.47	0.74	0.3	0.27	-0.28	0.5	0.27	0.29	0.74	0.45	-0.09	0.24	0.24	0.34

Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	7.2B	8.5B	8.3B	9.4B	13.1B	13.7B
Other Current Liab	574.7M	677.3M	673.3M	846.8M	1.2B	1.3B
Total Current Liabilities	893.9M	1.0B	1.0B	1.2B	1.5B	1.6B
Total Stockholder Equity	4.6B	5.8B	5.8B	6.7B	10.0B	10.5B
Property Plant And Equipment Net	1.5B	1.6B	1.7B	1.8B	1.8B	1.9B
Retained Earnings	4.6B	6.1B	7.6B	9.0B	13.2B	13.8B
Non Current Assets Total	4.1B	5.3B	5.2B	5.3B	6.8B	7.1B
Non Currrent Assets Other	119.6M	110.8M	299.1M	463.7M	732.4M	769.0M
Cash And Short Term Investments	1.4B	1.5B	1.2B	1.6B	4.0B	4.2B
Net Receivables	602.8M	664.9M	699.1M	828.1M	727.4M	385.1M
Good Will	1.2B	1.2B	1.2B	1.3B	1.8B	1.9B
Common Stock Shares Outstanding	631.9M	631.2M	624.2M	609.4M	599.3M	548.0M
Liabilities And Stockholders Equity	7.2B	8.5B	8.3B	9.4B	13.1B	13.7B
Non Current Liabilities Total	1.8B	1.6B	1.5B	1.4B	1.5B	832.8M
Inventory	802.3M	726.7M	875.5M	1.2B	1.1B	1.1B
Other Current Assets	283.3M	322.3M	305.9M	386.1M	495.4M	520.2M
Other Stockholder Equity	(466M)	(716.5M)	(2.2B)	(2.8B)	(3.6B)	(3.4B)
Total Liab	2.7B	2.7B	2.5B	2.6B	3.0B	3.1B
Property Plant And Equipment Gross	1.5B	1.6B	1.7B	2.7B	2.6B	2.7B
Total Current Assets	3.1B	3.2B	3.1B	4.0B	6.3B	6.6B
Accumulated Other Comprehensive Income	(161.1M)	(157.7M)	(254.9M)	(242.8M)	(244.5M)	(232.3M)
Short Long Term Debt Total	678.8M	694.9M	690.3M	691.3M	700M	497.7M
Other Liab	784.1M	1.1B	969.6M	797.6M	917.2M	963.1M
Net Debt	(488.3M)	(172.5M)	(77.7M)	(449.1M)	(2.3B)	(2.2B)
Accounts Payable	196.5M	204.5M	201.9M	201.4M	197.4M	142.6M
Cash	1.2B	862.8M	769M	1.1B	3.0B	3.2B
Other Assets	274M	1.2B	357.5M	783.1M	900.6M	945.6M
Long Term Debt	595M	595.7M	596.3M	597M	597.7M	434.9M
Common Stock Total Equity	218.1M	636.4M	642M	646.3M	743.2M	780.4M
Short Term Debt	25.5M	54.4M	51M	24.9M	46.8M	44.5M
Intangible Assets	331.4M	323.6M	285.2M	428.4M	1.2B	1.2B
Common Stock	636.4M	642M	646.3M	650.5M	654.8M	687.5M
Property Plant Equipment	1.1B	1.4B	1.6B	1.7B	2.0B	2.1B
Current Deferred Revenue	630.9M	798.4M	484M	953.9M	53.7M	51.0M
Treasury Stock	(1.0B)	(1.3B)	(1.9B)	(2.4B)	(2.2B)	(2.1B)
Short Term Investments	219.4M	604M	446.3M	500.5M	930.7M	977.2M
Net Tangible Assets	2.9B	3.4B	4.3B	4.4B	5.0B	5.3B
Retained Earnings Total Equity	3.7B	4.6B	6.1B	7.6B	8.7B	9.2B
Capital Surpluse	1.6B	1.4B	1.7B	2.0B	2.3B	1.2B
Long Term Investments	801.6M	1.8B	1.2B	583.9M	307.9M	565.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Edwards Historical Balance Sheet

Edwards Lifesciences Inventory

1.14 Billion

About Edwards Balance Sheet Analysis

Edwards Lifesciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Edwards Lifesciences balance sheet Correlations

Edwards Lifesciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Edwards Lifesciences balance sheet Accounts

Also Currently Popular

Additional Tools for Edwards Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Cash And Short Term Investments
Non Current Assets Total	+ 0.98	Total Assets
Other Current Assets	+ 0.98	Total Assets
Retained Earnings	+ 0.98	Total Stockholder Equity
Other Current Assets	+ 0.98	Total Stockholder Equity

Cash	- 0.97	Net Debt
Net Debt	- 0.95	Cash And Short Term Investments
Common Stock Shares Outstanding	- 0.94	Total Assets
Net Debt	- 0.92	Total Current Assets
Total Current Assets	- 0.92	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.92	Non Current Assets Total